fda warning letters compounded semaglutide tirzepatide september 2025 Have patients been harmed by unsafe drug compounding? – Partnership for Safe Medicines FDA warns against compounded GLP-1

cdc.gov/arthritis/osteoarthritis/index.html Centers for Medicare & Medicaid Services

Steering clear of any subsequent weight gain is key in preventing a resurgence of excess breast tissue and maintaining outcomes that are both long-lasting and cosmetically satisfying

Who should NOT take GLP-1 medications

Referral to clinical genetics or endocrinology may be appropriate for individuals with concerning family histories to guide treatment decisions

If you are prescribed a brand-name medication (Ozempic, Wegovy, Mounjaro, or Zepbound): A $79 prescription fee applies, and your prescription will be sent to your preferred pharmacy

The GIP component already provides some receptor tolerance overlap, but the glucagon agonism is entirely new territory